Скачать презентацию Anti-Mullerian Hormone in the pathophysiology of PCOS Roy Скачать презентацию Anti-Mullerian Hormone in the pathophysiology of PCOS Roy

6f74cd66b7a49ab678e59a8354ac14a8.ppt

  • Количество слайдов: 33

Anti-Mullerian Hormone in the pathophysiology of PCOS Roy Homburg Homerton University Hospital, London & Anti-Mullerian Hormone in the pathophysiology of PCOS Roy Homburg Homerton University Hospital, London & Barzilai Medical Centre, Ashkelon, Israel.

Anti-Müllerian hormone (TGF-β superfamily: Müllerian duct regression in male embryos) Maximal expression occurs in Anti-Müllerian hormone (TGF-β superfamily: Müllerian duct regression in male embryos) Maximal expression occurs in preantral and small antral follicles 1, 2 Expression disappears in maturing pre-ovulatory follicles (expression restricted to GCs of the cumulus)2 1. Laven et al. J Clin Endocrinol Metab 2004; 89: 318– 323; 2. Weenen et al. Mol Hum Reprod 2004; 10: 77– 83; 3. Cook et al. Fertil Steril 2000; 73: 859– 861; 4. La Marca et al. Hum Reprod 2004; 19: 2738– 2741; 5. La Marca et al. Hum Reprod 2006; 21: 3103– 3107

AMH is expressed in preantral and small antral follicles. AMH is thus a good AMH is expressed in preantral and small antral follicles. AMH is thus a good indicator of the size of the ovarian antral follicle pool.

PCOS morphology x 6 the density of pre-antral follicles compared with normal ovary. Webber PCOS morphology x 6 the density of pre-antral follicles compared with normal ovary. Webber et al, 2003 AMH serum concentrations in PCOS are high

PCOS n. PCOS – individual follicles produce more AMH n. Intrinsic property of PCOS PCOS n. PCOS – individual follicles produce more AMH n. Intrinsic property of PCOS granulosa cells or ? Due to A’s or insulin

Individual cell dysfunction in PCOS AMH concentrations in size-matched granulosa cells Anovulatory PCOS X Individual cell dysfunction in PCOS AMH concentrations in size-matched granulosa cells Anovulatory PCOS X 75 Ovulatory PCOS X 4 -18 Normal ovaries (Pigny et al, 2003; Pellatt et al, 2007)

AMH in pre-pubertal girls Crisosto et al, JCEM, 2007 AMH in pre-pubertal girls Crisosto et al, JCEM, 2007

Antral follicle dysfunction - Arrest of growth/anovulation Dewailly et al, 2007 n The size Antral follicle dysfunction - Arrest of growth/anovulation Dewailly et al, 2007 n The size of the 2 -5 mm follicle pool is an independent and important contributor to the follicular arrest of PCOS.

The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: A prospective cohort study. R. Homburg, A. Ray, P. Bhide, A. Gudi, A. Shah, P. Timms and K. Grayson Homerton University Hospital, London Hum Reprod, 2013

PCOS & AMH n Pre- antral and small antral follicles produce AMH n x PCOS & AMH n Pre- antral and small antral follicles produce AMH n x 6 the density of pre-antral follicles compared with the normal ovary in PCOS. (Webber et al, 2003) n High AMH levels in PCOS also due to increased production by individual follicles (Pellatt et al, 2007) n Some have suggested that asymptomatic polycystic morphology (PCOM) is not an entity but a mild variation of normal.

Study aims 1. To define the place of polycystic ovarian morphology (PCOM) in the Study aims 1. To define the place of polycystic ovarian morphology (PCOM) in the hierarchy of polycystic ovary syndrome (PCOS). 2. To investigate the relationship of AMH to gonadotrophin concentrations. Homburg et al, Hum Reprod, 2013

Homburg et al, Hum Reprod, 2013 n Data was collected prospectively from three groups Homburg et al, Hum Reprod, 2013 n Data was collected prospectively from three groups of women before undergoing fertility treatment: n PCOS (Rotterdam criteria) n=90 n Polycystic ovarian morphology but no symptoms (PCOM) n=35 n Normal ovaries – controls matched for age and BMI n=90

Matched for age and BMI Groups No Controls 90 PCOM 35 PCOS 90 P Matched for age and BMI Groups No Controls 90 PCOM 35 PCOS 90 P Age BMI 32. 5 (3. 3) 24. 8 (2. 6) 32. 1 (4. 2) 24. 7 (2. 6) 31. 6 (4. 4) NS 24. 9 (2. 4) NS Homburg et al, Hum Reprod, 2013

AMH concentrations Groups No AMH (pmol/l) Controls 90 23. 6 (15. 0)* PCOM 35 AMH concentrations Groups No AMH (pmol/l) Controls 90 23. 6 (15. 0)* PCOM 35 52. 2 (35. 0)** PCOS 90 77. 6 (61. 0)*** P<0. 05 PCOM vs PCOS P<0. 001 Controls vs PCOM Controls vs PCOS AMH measured by Beckman-Coulter Gen II assay

Mean values and 95% confidence intervals for AMH (pmol/l) in the group of controls Mean values and 95% confidence intervals for AMH (pmol/l) in the group of controls (N), PCOM and PCOS.

Conclusion n. Serum AMH concentrations are capable of differentiating between normal ovaries, PCOM and Conclusion n. Serum AMH concentrations are capable of differentiating between normal ovaries, PCOM and PCOS. n. Suggests that the number of small follicles determines the severity of the syndrome. Homburg et al, Hum Reprod, 2013

AMH levels in PCOS according to the menstrual status Pigny et al. , 2006 AMH levels in PCOS according to the menstrual status Pigny et al. , 2006 Menstrual status AMH (pmol/L) Number of patients Regular cycles Oligomen- Amenorrhea 58. 4 (31. 9) 83. 6 (60. 3) 18 120. 4 (50. 8) 44 9 Higher AMH values in oligo - amenorrheic women and in women with hyperandrogenism

Kolhapur PCOS study – ‘MAPIN’ study 2007 – 2011 1257 women with PCOS – Kolhapur PCOS study – ‘MAPIN’ study 2007 – 2011 1257 women with PCOS – Rotterdam Criteria Analysis ready for 492 Clinical Endocrinology and Metabolism Ultrasound (Kulkarni, Gudi, Homburg and Conway)

Kolhapur PCOS study – BMI distribution 60 50 40 30 20 10 0 13 Kolhapur PCOS study – BMI distribution 60 50 40 30 20 10 0 13 15 17 19 21 23 25 27 29 31 33 35 37 39 47

Kolhapur PCOS study – BMI quintiles n age BMI TSH Testo Insulin AMH 1 Kolhapur PCOS study – BMI quintiles n age BMI TSH Testo Insulin AMH 1 96 23 17. 4 2. 4 42 6. 1 3. 65 2 89 24 20. 9* 2. 1 53* 9. 7 3. 67 3 4 5 105 92 93 25* 25 27* 23. 3* 26. 1** 30. 9** 2. 8 2. 7 3. 3* 58* 62* 67* 12. 2* 12. 9* 15. 0** 4. 01* 4. 33* 4. 88* (Kulkarni, Gudi, Homburg and Conway)

Kolhapur PCOS study – types of diet Kolhapur PCOS study – types of diet

Kolhapur PCOS study - diet n BMI WHR LH Testo Andro SHBG Insulin AMH Kolhapur PCOS study - diet n BMI WHR LH Testo Andro SHBG Insulin AMH 1 Carb 50 17. 1 0. 82 10. 5 44 2. 74 30 5. 8 3. 69 Veg 219 22. 3* 0. 85 9. 3 54* 2. 84 40 10. 7* 3. 82* Non Veg 170 25. 7* 0. 84 9. 3 64* 2. 61 32 12. 6* 4. 36* Junk 51 30. 6** 0. 85 9. 9 68* 3. 15 30 13. 7** 5. 11**

Kolhapur PCOS study – hirsutism F-G Score Kolhapur PCOS study – hirsutism F-G Score

Kolhapur PCOS study - hirsutism n age BMI TSH Testo Insulin AMH <8 72 Kolhapur PCOS study - hirsutism n age BMI TSH Testo Insulin AMH <8 72 23 18. 4 2. 6 42 7. 8 3. 86 8 -9 10 -11 12 -13 >13 130 102 92 92 24 25* 26* 27* 21. 0* 24. 1* 26. 4** 29. 0** 2. 3 2. 8* 2. 7** 3. 2** 52 62 61 70 9. 3 12. 3* 11. 2 15. 4** 3. 63 4. 21 4. 39* 4. 70*

Effect of aging on PCOS n Women with PCOS gain regular menstrual cycles when Effect of aging on PCOS n Women with PCOS gain regular menstrual cycles when aging n Menstrual cycle restored in those with a smaller follicle count Elting et al, 2000, 2003

Lack of influence of endogenous FSH n FSH levels generally lower than normal but Lack of influence of endogenous FSH n FSH levels generally lower than normal but within normal limits. n Adding exogenous FSH (CC, low dose FSH) restores normal follicular growth. Increased responsiveness to exogenous FSH n Suggests an endogenous inhibition of FSH action in PCOS.

Mean values and 95% confidence intervals for FSH (IU) in the groups of control Mean values and 95% confidence intervals for FSH (IU) in the groups of control (N), PCOM and PCOS.

Possible role of AMH in the pathophysiology of PCOS • The size of the Possible role of AMH in the pathophysiology of PCOS • The size of the 2 -5 mm follicle pool is an independent and important contributor to the follicular arrest of PCOS. (Dewailly et al, 2007) • AMH concentrations are very high in PCOS. The higher they are, the greater the ovulatory disturbance. (Pigny et al, 2006) • Action of FSH in promoting follicular growth is counteracted by AMH. (Pigny et al, 2003; Weenen et al, 2004; Durlinger et al, 2001)

A excess Anovulation LH +insulin Multiple small follicles AMH FSH action Anovulation progesterone A excess Anovulation LH +insulin Multiple small follicles AMH FSH action Anovulation progesterone

Treatment n Weight loss – Lower AMH at start do better if AMH falls Treatment n Weight loss – Lower AMH at start do better if AMH falls ovulation (Moran et al, 2007) n CC in obese & laparoscopic ovarian drilling – Response dependent on initial AMH conc. (Amer et al, 2009) n Metformin – Very long time for AMH to fall (Fleming et al, 2005) n FSH – AMH falls with Rx (Catteau-Jonnard, 2007)

Conclusions n. The severity of symptoms of PCOS is positively related to the number Conclusions n. The severity of symptoms of PCOS is positively related to the number of small follicles reflected by AMH. n. AMH may play an important part in the pathophysiology of PCOS.